Bioventus BVS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $34.54M+179% | $27.27M+158% | $9.35M+117% | -$501K+99.1% | -$43.99M-59.6% | ||
| $46.35M-6.6% | $47.01M-5.1% | $47.72M-3.8% | $48.59M-5.0% | $49.64M-5.8% | ||
| $13.52M+6.5% | $12.67M-4.5% | $11.25M-13.7% | $10.56M-14.6% | $12.7M+228% | ||
| $102.94M+304% | $74.67M+92.5% | $56.03M+87.7% | $36.25M— | $25.47M— | ||
| $2.31M+49.9% | $2.56M+155% | $2.56M+219% | $2.15M-22.6% | $1.54M-62.4% | ||
| -$3M-113% | -$3.25M-114% | $21.44M— | $21.85M— | $23.14M— | ||
| $40M+100% | $45M+200% | $35M— | $25M+257% | $20M-31.0% | ||
| -$86.23M-73.3% | -$62.14M-13.1% | -$76.55M-533% | -$56.57M— | -$49.75M— | ||
| $13.04M— | $9.66M— | —— | —— | —— | ||
| $100.63M+321% | $72.11M+90.8% | $53.47M+84.1% | $34.1M+304% | $23.93M+768% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bioventus generate?
- Bioventus (BVS) generated $102.9M in operating cash flow over the trailing twelve months.
- What is Bioventus's free cash flow?
- After $2.3M of capital expenditures, Bioventus's free cash flow was $100.6M over the trailing twelve months, up 320.5% year over year.
- Where does Bioventus's cash flow data come from?
- Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
